Cargando…
Nivolumab‐induced fatal myocarditis: A case report
KEY CLINICAL MESSAGE: Baseline assessment and interval monitoring with a careful history, clinical examination, laboratory work‐up, and noninvasive imaging modalities may be beneficial for early detection of immune checkpoint inhibitor‐associated side effects. ABSTRACT: Previous reports of immune ch...
Autores principales: | Bharathidasan, Kavya, Abdelnabi, Mahmoud, Abdelmalek, John, Sekhon, Jasmine, Butler, William, Quirch, Miguel, Sosa, Erwin Argueta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167613/ https://www.ncbi.nlm.nih.gov/pubmed/37180331 http://dx.doi.org/10.1002/ccr3.7306 |
Ejemplares similares
-
Nivolumab-Induced Myocarditis Concomitant with Myasthenia Gravis
por: Fukasawa, Yoko, et al.
Publicado: (2017) -
Ipilimumab/nivolumab/tozinameran: Acute myocarditis: 3 case reports
Publicado: (2022) -
Nivolumab-Induced Myasthenia Gravis Concomitant With Myocarditis, Myositis, and Hepatitis
por: Bawek, Sawyer J, et al.
Publicado: (2021) -
A Case Report: An Acute Thrombus in the Femoral Artery following Total Hip Arthroplasty
por: GBS, Varun, et al.
Publicado: (2016) -
Myocarditis following COVID-19 mRNA vaccination
por: Parmar, Kanak, et al.
Publicado: (2021)